TWD 91.2
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 151.49 Million TWD | 16.63% |
2022 | 129.89 Million TWD | 7.41% |
2021 | 120.93 Million TWD | 0.66% |
2020 | 120.13 Million TWD | 11.53% |
2019 | 107.72 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 37.55 Million TWD | 3.96% |
2024 Q1 | 36.11 Million TWD | -4.46% |
2023 Q2 | 36.82 Million TWD | 0.0% |
2023 Q4 | 37.8 Million TWD | 0.0% |
2023 FY | 151.5 Million TWD | 16.63% |
2023 Q1 | 36.82 Million TWD | 15.32% |
2023 Q3 | 37.8 Million TWD | 2.65% |
2022 Q3 | 31.93 Million TWD | 0.0% |
2022 FY | 129.89 Million TWD | 7.41% |
2022 Q4 | 31.93 Million TWD | 0.0% |
2021 FY | 120.93 Million TWD | 0.66% |
2020 FY | 120.13 Million TWD | 11.53% |
2019 FY | 107.72 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Allied Biotech Corporation | 157.72 Million TWD | 3.949% |
GeneFerm Biotechnology Co., Ltd. | 132.78 Million TWD | -14.091% |
Easywell Biomedicals, Inc. | 333.45 Million TWD | 54.568% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 92.075% |
Synmosa Biopharma Corporation | 1.49 Billion TWD | 89.897% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 92.945% |
Center Laboratories, Inc. | 697.35 Million TWD | 78.276% |
Tien Liang BioTech Co., Ltd. | 267.27 Million TWD | 43.318% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 67.675% |
InnoPharmax Inc. | 82.29 Million TWD | -84.088% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | 38.072% |
Excelsior Biopharma Inc. | 388.05 Million TWD | 60.96% |
DV Biomed Co., Ltd. | 575.24 Million TWD | 73.664% |
Foresee Pharmaceuticals Co., Ltd. | 1.12 Billion TWD | 86.493% |
Handa Pharmaceuticals, Inc. | 399.14 Million TWD | 62.045% |
UniPharma Co., Ltd. | 78.32 Million TWD | -93.431% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | 61.833% |
Alar Pharmaceuticals Inc. | 83.74 Million TWD | -80.903% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -25490.709% |
Bioray Biotech Co., Ltd | 96.98 Million TWD | -56.211% |
TSH Biopharm Corporation Limited | 336.26 Million TWD | 54.948% |